Anti-mouse PD-L1 (B7-H1)-InVivo

目录号：A2115         批次号: A211537

       克隆号：10F.9G2

打印

Anti-mouse PD-L1 (B7-H1)-InVivo (克隆号：10F.9G2)单克隆抗体可与小鼠 PD-L1（也称为B7-H1、CD274）发生反应。10F.9G2 抗体已被证明可以阻断 PD-L1 和 PD-1 之间以及 PD-L1 和 B7-1 (CD80) 之间的相互作用。

抗体信息

克隆号 10F.9G2
免疫原 Mouse CD274
配制 PBS Buffer, PH 7.4
推荐同型对照 Rat,IgG2b, κ
应用 in vivo PD-L1 blockade,IHC (frozen),FCM
来源 CHO
储存条件
(自收到货起)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
除菌 0.2 μM filtered
纯度 99%
蛋白浓度 6.89 mg/mL
内毒素 ＜1EU/mg

客户使用selleck产品的实验数据

数据来源于[Data independently produced by , ]

Anti-mouse PD-L1 (B7-H1)-InVivo在文献中得到引用

NRIR promotes immune escape in hepatocellular cancer by regulating IFNγ-induced PD-L1 expression [ J Adv Res, 2025, S2090-1232(25)00133-X] PubMed: 40023249
Tumor microenvironment-associated oxidative stress impairs SIRT1 secretion to suppress anti-tumor immune response [ Cell Rep, 2025, 44(5):115679] PubMed: 40343797
Lipin1-dependent transcriptional inactivation of SREBPs contributes to selinexor sensitivity in multiple myeloma [ Acta Pharmacol Sin, 2025, 10.1038/s41401-025-01553-3] PubMed: 40229499
ENTPD8 overexpression enhances anti-PD-L1 therapy in hepatocellular carcinoma via miR-214-5p inhibition [ iScience, 2025, 28(2):111819] PubMed: 39995876
Interleukin-17A facilitates tumor progression via upregulating programmed death ligand-1 expression in hepatocellular carcinoma [ World J Gastrointest Oncol, 2025, 17(1):97831] PubMed: 39817127
Asiaticoside enhances the anti-tumor effect of anti-PDL1 by regulating T cell activity through increasing LCK activity [ Pathol Res Pract, 2025, 271:155995] PubMed: 40373489
Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec-15 axis in immune escape [ Cancer Commun (Lond), 2024, 10.1002/cac2.12545] PubMed: 38734931
Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec-15 axis in immune escape [ Cancer Commun (Lond), 2024, 44(6):670-694] PubMed: 38734931
Bioactive nanocomposite hydrogel enhances postoperative immunotherapy and bone reconstruction for osteosarcoma treatment [ Biomaterials, 2024, 312:122714] PubMed: 39079462
TNKS1BP1 facilitates ubiquitination of CNOT4 by TRIM21 to promote hepatocellular carcinoma progression and immune evasion [ Cell Death Dis, 2024, 15(7):511.] PubMed: 39019859

禁止用于人体及治疗！